Watch MLYS. Know when insiders buy.
One email the day a filing lands. Free.
MLYS
Mineralys Therapeutics, Inc.
21.10
−0.48 −2.22%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · insiders 25, shorts 58
Insiders, 90 days
−$5.4M
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.9BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$349.6MNET CASH $138.2M52W 20.30 – 47.33NEXT EARNINGS Nov 10 EST.SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose MLYS in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on MLYS in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.